Agilent Technologies (A) Stock Forecast & Price Target

$146.89 -1.74 (-1.17%)

As of 03:49 PM Eastern

Agilent Technologies - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 14 Analyst Ratings

Sell
1

Hold
6

Buy
7

Based on 14 Wall Street analysts who have issued ratings for Agilent Technologies in the last 12 months, the stock has a consensus rating of "Hold." Out of the 14 analysts, 1 has given a sell rating, 6 have given a hold rating, and 7 have given a buy rating for A.

Consensus Price Target

$143.62
-2.23% Downside

According to the 14 analysts' twelve-month price targets for Agilent Technologies, the average price target is $143.62. The highest price target for A is $165.00, while the lowest price target for A is $90.00. The average price target represents a forecasted downside of -2.23% from the current price of $146.89.

Get the Latest News and Ratings for A and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Agilent Technologies and its competitors.

A Analyst Ratings Over Time

Type	Current Forecast 2/5/24 to 2/4/25	1 Month Ago 1/6/24 to 1/5/25	3 Months Ago 11/7/23 to 11/6/24	1 Year Ago 2/5/23 to 2/5/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	7 Buy rating(s)	7 Buy rating(s)	8 Buy rating(s)	9 Buy rating(s)
Hold	6 Hold rating(s)	6 Hold rating(s)	5 Hold rating(s)	6 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$143.62	$143.62	$144.36	$137.44
Forecasted Upside	-2.23% Downside	5.84% Upside	4.77% Upside	3.48% Upside
Consensus Rating	Hold	Hold	Moderate Buy	Moderate Buy

A Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

A Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Agilent Technologies Stock vs. The Competition

Type	Agilent Technologies	Medical Companies	S&P 500
Consensus Rating Score	2.43	2.82	2.53
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	-2.75% Downside	15,878.54% Upside	12.87% Upside
News Sentiment Rating	Positive News See Recent A News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/19/2024	Citigroup 3 of 5 stars	P. Donnelly Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy	$165.00	+23.96%
12/13/2024	Bank of America 3 of 5 stars		Lower Target	Neutral ➝ Neutral	$153.00 ➝ $150.00	+8.93%
12/9/2024	Wells Fargo & Company 3 of 5 stars	B. Couillard Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$157.00 ➝ $155.00	+7.66%
11/27/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Underweight ➝ Underweight	$145.00 ➝ $135.00	+0.48%
11/26/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Market Perform ➝ Market Perform	$140.00 ➝ $135.00	+1.41%
11/26/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$165.00 ➝ $160.00	+22.14%
10/1/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	In-Line ➝ In-Line	$135.00 ➝ $145.00	-0.46%
8/26/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy	$151.00	+7.19%
8/22/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$141.00 ➝ $150.00	+6.47%
8/22/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$153.00 ➝ $160.00	+13.71%
Get the Latest News and Ratings for A and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Agilent Technologies and its competitors with MarketBeat's FREE daily newsletter.
6/27/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Schenkel Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Peer Perform
6/3/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Hold	$152.00 ➝ $135.00	+3.78%
5/30/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$147.00 ➝ $136.00	-6.52%
3/26/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$67.00 ➝ $90.00	-38.30%
12/7/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$128.00 ➝ $145.00	+12.47%
8/16/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$160.00 ➝ $150.00	+19.38%
5/24/2023	888 Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Maintains
5/24/2023	58.com Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Maintains
5/24/2023	SVB Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform	$170.00 ➝ $145.00	+12.72%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 03:50 PM ET.

Should I Buy Agilent Technologies Stock? A Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, January 28, 2025. Please send any questions or comments about these Agilent Technologies pros and cons to contact@marketbeat.com.

Agilent Technologies
Bull Case

Here are some ways that investors could benefit from investing in Agilent Technologies, Inc.:

Agilent Technologies, Inc. recently reported quarterly earnings of $1.46 per share, exceeding analysts' expectations of $1.41, indicating strong financial performance and effective management.
The company has shown a year-over-year revenue increase of 0.8%, with revenues reaching $1.70 billion, suggesting consistent demand for its products and services in the life sciences and diagnostics sectors.
Agilent Technologies, Inc. has a solid return on equity of 25.43%, which reflects its ability to generate profit from shareholders' equity, a positive indicator for potential investors.
The current stock price is $144.77, which is near its 1-year high of $155.35, indicating strong market performance and investor confidence.
The company has recently increased its quarterly dividend to $0.248 per share, representing a yield of 0.70%, which can provide a steady income stream for investors.

Agilent Technologies
Bear Case

Investors should be bearish about investing in Agilent Technologies, Inc. for these reasons:

Despite the recent earnings beat, the stock has been rated with a mix of hold and buy ratings, with one analyst issuing a sell rating, indicating some uncertainty in market sentiment.
Analysts have varied opinions on the stock price, with some lowering their price targets, such as Barclays reducing it from $145.00 to $135.00, which may suggest potential downward pressure on the stock.
The company has a relatively high P/E ratio of 32.75, which could indicate that the stock is overvalued compared to its earnings, making it a riskier investment.
Agilent Technologies, Inc. operates in a competitive market, and any shifts in demand or technological advancements by competitors could impact its market share and profitability.
The dividend payout ratio is currently at 22.40%, which, while sustainable, may limit the company's ability to reinvest in growth opportunities, potentially affecting long-term performance.

A Forecast - Frequently Asked Questions

: According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Agilent Technologies is $143.62, with a high forecast of $165.00 and a low forecast of $90.00.
: 14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last twelve months. There is currently 1 sell rating, 6 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" A shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in A, but not buy additional shares or sell existing shares.
: According to analysts, Agilent Technologies's stock has a predicted downside of -2.23% based on their 12-month stock forecasts.
: Agilent Technologies has been rated by research analysts at Bank of America, Barclays, Citigroup, JPMorgan Chase & Co., Sanford C. Bernstein, and Wells Fargo & Company in the past 90 days.
: Analysts like Agilent Technologies less than other "medical" companies. The consensus rating for Agilent Technologies is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how A compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

This page (NYSE:A) was last updated on 2/4/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Agilent Technologies (A) Stock Forecast & Price Target